Trial intelligence / Profile preview

Perioperative 5-FU in Operable Breast Cancer

NCT00301548Phase 2Completed

Sponsor
European Institute of Oncology
Start
Feb 2000
Modality
Small Molecules
01

Overview

A Phase 2 trial of fluorouracil in breast cancer, sponsored by European Institute of Oncology. Started Feb 2000; status: completed.

02

Drugs

fluorouracil
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00301548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00301548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call